4:49 pm Acceleron Pharma and Celgene (CELG) announce interim clinical data for sotatercept demonstrating dose dependent increases in hemoglobin in patients with end stage renal disease on hemodialysis

more

View todays social media effects on XLRN

View the latest stocks trending across Twitter. Click to view dashboard

See who Acceleron is hiring next, click here to view